Science Explorer Interactive view Map
Company · La Chaux-de-Fonds · Switzerland

Rhizen Pharmaceuticals (Switzerland)

rhizen.comROR OpenAlex
Research works
56
▼ 11% vs 2013–17
Citations
394
7.0 per fractional work
Top-10% rate
2.2%
record average 16.5%
Open access
31%
world 28%

Not ranked overall: Rhizen Pharmaceuticals (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Rhizen Pharmaceuticals (Switzerland)?

By fractional works in all years, weighted toward what it does more of than the world: Rituximab, Cancer, Prognostic Factors, Cancer Therapy, Antioxidant, Inflammation, Lymphoma and PET Imaging.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Rituximab7▲ 76×2 topics
  2. Cancer6▲ 6.9×15 topics
  3. Inflammation6▲ 4.1×17 topics
  4. Prognostic Factors5▲ 20×4 topics
  5. Cancer Therapy5▲ 14×7 topics
  6. Antioxidant4▲ 11×14 topics
  7. Lymphoma4▲ 48×3 topics
  8. PET Imaging4▲ 31×3 topics
  9. Chronic Lymphocytic Leukemia3▲ 123×1 topic
  10. Classification3▲ 17×1 topic
  11. Genomic Aberrations3▲ 123×1 topic
  12. Molecular Profiling3▲ 51×1 topic
  13. Ion Channels3▲ 25×2 topics
  14. Diabetes3▲ 10×9 topics
  15. Anti-inflammatory3▲ 17×10 topics
  16. Oxidative Stress3▲ 2.7×9 topics
  17. Tumor Microenvironment3▲ 14×3 topics
  18. Medicinal Plants2▲ 12×6 topics
  19. BRCA Mutation2▲ 246×1 topic
  20. PARP Inhibitors2▲ 246×1 topic
  21. Metabolism2▲ 6.2×9 topics
  22. Antioxidants2▲ 8.6×6 topics
  23. Bioactive Compounds2▲ 20×4 topics
  24. Cancer Prevention2▲ 15×6 topics
  25. HIF-12▲ 53×1 topic
  26. Warburg Effect2▲ 53×1 topic
  27. Antioxidant Activity2▲ 6.3×6 topics
  28. Pharmacology2▲ 10×7 topics
  29. Flavonoids2▲ 13×4 topics
  30. Neuronal Function2▲ 28×2 topics
  31. Membrane Proteins2▲ 16×2 topics
  32. Nociception2▲ 47×2 topics
  33. Calcium Signaling2▲ 22×1 topic
  34. TRP Channels2▲ 209×1 topic
  35. Apoptosis2▲ 7.0×4 topics
  36. Calcium Channels2▲ 36×1 topic
  37. Cell Signaling2▲ 8.2×2 topics
  38. Voltage-Gated Channels2▲ 36×1 topic
  39. Breast Cancer1▲ 9.1×2 topics
  40. Targeted Therapy1▲ 12×2 topics

Which research topics does Rhizen Pharmaceuticals (Switzerland) publish most on?

By volume in 2022–2025: PARP inhibition in cancer therapy, Chronic Lymphocytic Leukemia Research, Advanced Breast Cancer Therapies and Lymphoma Diagnosis and Treatment.

PARP inhibition in cance…1PARP inhibition in cancer therapy: 1 fractional worksChronic Lymphocytic Leuk…1Chronic Lymphocytic Leukemia Research: 1 fractional worksAdvanced Breast Cancer T…0Advanced Breast Cancer Therapies: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksCutaneous lymphoproliferative disorders research: 0 fractional worksPI3K/AKT/mTOR signaling in cancer: 0 fractional worksPhytochemical compounds biological activities: 0 fractional worksCAR-T cell therapy research: 0 fractional worksT-cell and Retrovirus Studies: 0 fractional worksRice Cultivation and Yield Improvement: 0 fractional works
OncologyGeneticsPulmonary and Respiratory MedicinePathology and Forensic Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 PARP inhibition in cancer therapy Oncology 1 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 1 works
  3. 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  5. 5 Cutaneous lymphoproliferative disorders research Dermatology 0 works
  6. 6 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
  7. 7 Phytochemical compounds biological activities Molecular Biology 0 works
  8. 8 CAR-T cell therapy research Oncology 0 works
  9. 9 T-cell and Retrovirus Studies Immunology 0 works
  10. 10 Rice Cultivation and Yield Improvement Plant Science 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.8%not open69.2%

World: 28% of research is openly available.

with international co-authors55.4%domestic only44.6%

World: 19% is written across borders.

How has Rhizen Pharmaceuticals (Switzerland)'s research output changed?

Output in 2018–2022 was 11% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in La Chaux-de-Fonds

All research institutions in La Chaux-de-Fonds

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.